




Searching News Database: Orphan Medical
HSMN NewsFeed - 16 Aug 2010
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
HSMN NewsFeed - 26 Mar 2007
Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Additional items found! 13

Members Archive contains
13 additional stories matching:
Orphan Medical
(Password required)
Orphan Medical
(Password required)